Cargando…
Cancer as a moving target: understanding the composition and rebound growth kinetics of recurrent tumors
We introduce a stochastic branching process model of diversity in recurrent tumors whose growth is driven by drug resistance. Here, an initially declining population can escape certain extinction via the production of mutants whose fitness is drawn at random from a mutational fitness landscape. Usin...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567471/ https://www.ncbi.nlm.nih.gov/pubmed/23396647 http://dx.doi.org/10.1111/eva.12019 |
_version_ | 1782258708200292352 |
---|---|
author | Foo, Jasmine Leder, Kevin Mumenthaler, Shannon M |
author_facet | Foo, Jasmine Leder, Kevin Mumenthaler, Shannon M |
author_sort | Foo, Jasmine |
collection | PubMed |
description | We introduce a stochastic branching process model of diversity in recurrent tumors whose growth is driven by drug resistance. Here, an initially declining population can escape certain extinction via the production of mutants whose fitness is drawn at random from a mutational fitness landscape. Using a combination of analytical and computational techniques, we study the rebound growth kinetics and composition of the relapsed tumor. We find that the diversity of relapsed tumors is strongly affected by the shape of the mutational fitness distribution. Interestingly, the model exhibits a qualitative shift in behavior depending on the balance between mutation rate and initial population size. In high mutation settings, recurrence timing is a strong predictor of the diversity of the relapsed tumor, whereas in the low mutation rate regime, recurrence timing is a good predictor of tumor aggressiveness. Analysis reveals that in the high mutation regime, stochasticity in recurrence timing is driven by the random survival of small resistant populations rather than variability in production of resistance from the sensitive population, whereas the opposite is true in the low mutation rate setting. These conclusions contribute to an evolutionary understanding of the suitability of tumor size and time of recurrence as prognostic and predictive factors in cancer. |
format | Online Article Text |
id | pubmed-3567471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-35674712013-02-08 Cancer as a moving target: understanding the composition and rebound growth kinetics of recurrent tumors Foo, Jasmine Leder, Kevin Mumenthaler, Shannon M Evol Appl Original Articles We introduce a stochastic branching process model of diversity in recurrent tumors whose growth is driven by drug resistance. Here, an initially declining population can escape certain extinction via the production of mutants whose fitness is drawn at random from a mutational fitness landscape. Using a combination of analytical and computational techniques, we study the rebound growth kinetics and composition of the relapsed tumor. We find that the diversity of relapsed tumors is strongly affected by the shape of the mutational fitness distribution. Interestingly, the model exhibits a qualitative shift in behavior depending on the balance between mutation rate and initial population size. In high mutation settings, recurrence timing is a strong predictor of the diversity of the relapsed tumor, whereas in the low mutation rate regime, recurrence timing is a good predictor of tumor aggressiveness. Analysis reveals that in the high mutation regime, stochasticity in recurrence timing is driven by the random survival of small resistant populations rather than variability in production of resistance from the sensitive population, whereas the opposite is true in the low mutation rate setting. These conclusions contribute to an evolutionary understanding of the suitability of tumor size and time of recurrence as prognostic and predictive factors in cancer. Blackwell Publishing Ltd 2013-01 2012-11-16 /pmc/articles/PMC3567471/ /pubmed/23396647 http://dx.doi.org/10.1111/eva.12019 Text en Journal compilation © 2013 Blackwell Publishing Ltd http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. |
spellingShingle | Original Articles Foo, Jasmine Leder, Kevin Mumenthaler, Shannon M Cancer as a moving target: understanding the composition and rebound growth kinetics of recurrent tumors |
title | Cancer as a moving target: understanding the composition and rebound growth kinetics of recurrent tumors |
title_full | Cancer as a moving target: understanding the composition and rebound growth kinetics of recurrent tumors |
title_fullStr | Cancer as a moving target: understanding the composition and rebound growth kinetics of recurrent tumors |
title_full_unstemmed | Cancer as a moving target: understanding the composition and rebound growth kinetics of recurrent tumors |
title_short | Cancer as a moving target: understanding the composition and rebound growth kinetics of recurrent tumors |
title_sort | cancer as a moving target: understanding the composition and rebound growth kinetics of recurrent tumors |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567471/ https://www.ncbi.nlm.nih.gov/pubmed/23396647 http://dx.doi.org/10.1111/eva.12019 |
work_keys_str_mv | AT foojasmine cancerasamovingtargetunderstandingthecompositionandreboundgrowthkineticsofrecurrenttumors AT lederkevin cancerasamovingtargetunderstandingthecompositionandreboundgrowthkineticsofrecurrenttumors AT mumenthalershannonm cancerasamovingtargetunderstandingthecompositionandreboundgrowthkineticsofrecurrenttumors |